A 45-year-old man with BMI 33 kg/m² and metabolic syndrome is found to have mildly elevated ALT and ultrasound evidence of fatty infiltration of the liver. Viral hepatitis serology is negative and alcohol intake is modest. What is the cornerstone of management to improve his liver disease and cardiometabolic risk?